Disease Management
613 articles
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
Genetic Profiling Leads to a Clinical Trial
With treatment not working and nothing to lose, Cathleen Janosko did her research and got help finding a clinical trial to match her tumor’s mutation.
“Radical Collaboration” to Find Cures for the Deadliest Cancers
Break Through Cancer was founded to promote collaboration between major research institutions, in order to develop cures for the deadliest cancers.
Risk Factors and Symptoms of Pancreatic Cancer
In this webinar oncologist Dr. Shaalan Beg outlines pancreatic cancer risk factors and gastroenterologist Dr. Oscar Alvarez explains how he looks at symptoms.
Chemo Before Surgery Doubles Overall Survival in Some Patients
Dr. Marco Del Chiaro explains the results of an international study of outcomes for patients who had neoadjuvant treatment before surgery.
A Charley Horse Led to Pancreatic Neuroendocrine Tumor Discovery
Mark Head thought he had a Charley horse, but it turned out to be a more serious deep vein thrombosis. A scan for the source found a pancreatic neuroendocrine tumor.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.
A Family Tree Bent but Not Broken by Pancreatic Cancer
When Kay Zedd Kesser looks around her family tree, she sees pancreatic cancer everywhere. But screening saved Kay’s life.
Let’s Win! Pancreatic Cancer Unveils Spanish-Language Website To Connect Latinos With Pancreatic Cancer Information, Resources, And Community
Let’s Win! Pancreatic Cancer announces a Spanish-language platform to connect the Latino community to pancreatic cancer resources in Spanish.
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
President Jimmy Carter, Honorary Chair
Jimmy Carter (James Earl Carter, Jr.), thirty-ninth president of the United States, was born October 1, 1924, in the small farming town of Plains, Georgia, and grew up in the nearby community of Archery. His father, James Earl Carter, Sr., was a farmer and businessman; his mother, Lillian Gordy Carter, a registered nurse. He was […]
Maintenance Chemotherapy for Stable Metastatic Pancreatic Cancer
A clinical trial tests the diabetes drug metformin and transplant rejection preventative rapamycin to act as maintenance chemotherapy for pancreatic cancer.
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.